Polymorphisms of survivin promoter are associated with risk of esophageal squamous cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 10, 2009, Pages 1341-1349

  Yang, Xiaoya ^a,b   Xiong, Gang ^a   Chen, Xuedan ^a   Xu, Xueqing ^a   Wang, Kai ^a   Fu, Yong ^a   Yang, Kang ^a   Bai, Yun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

Esophageal squamous cell carcinoma; Expression; Polymorphism; Survivin; Susceptibility

Indexed keywords

SURVIVIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER TISSUE; CHINESE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE CONSTRUCT; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; HAPLOTYPES; HUMANS; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; PROMOTER REGIONS, GENETIC; SURVIVAL RATE;

EID: 69049112803     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0575-7     Document Type: Article

References (25)

1. C Adida PL Crotty J McGrath D Berrebi J Diebold DC Altieri 1998 Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation Am J Pathol 152 43 49
2. DC Altieri 2001 The molecular basis and potential role of survivin in cancer diagnosis and therapy Trends Mol Med 7 542 547 10.1016/S1471-4914(01) 02243-2
3. DC Altieri 2003 Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 8581 8589 10.1038/sj.onc.1207113
4. G Ambrosini C Adida DC Altieri 1997 A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3 917 921 10.1038/nm0897-917
5. KG Ardlie L Kruglyak M Seielstad 2002 Patterns of linkage disequilibrium in the human genome Nat Rev Genet 3 299 309 10.1038/nrg777
6. AA Borbely M Murvai K Szarka J Konya L Gergely Z Hernadi G Veress 2007 Survivin promoter polymorphism and cervical carcinogenesis J Clin Pathol 60 303 306 10.1136/jcp.2006.037804
7. SB Gabriel SF Schaffner H Nguyen JM Moore J Roy B Blumenstiel J Higgins M DeFelice A Lochner M Faggart SN Liu-Cordero C Rotimi A Adeyemo R Cooper R Ward ES Lander MJ Daly D Altshuler 2002 The structure of haplotype blocks in the human genome Science 296 2225 2229 10.1126/science.1069424
8. M Ikeguchi N Kaibara 2002 Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma Br J Cancer 87 883 887 10.1038/sj.bjc.6600546
9. M Ikeguchi K Yamaguchi N Kaibara 2003 Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer Tumour Biol 24 40 45 10.1159/000070659
10. T Ito K Shiraki K Sugimoto T Yamanaka K Fujikawa M Ito K Takase M Moriyama H Kawano M Hayashida T Nakano A Suzuki 2000 Survivin promotes cell proliferation in human hepatocellular carcinoma Hepatology 31 1080 1085 10.1053/he.2000.6496
11. JS Jang KM Kim KH Kang JE Choi WK Lee CH Kim YM Kang S Kam IS Kim JE Jun TH Jung JY Park 2008 Polymorphisms in the survivin gene and the risk of lung cancer Lung Cancer 60 1 31 39
12. X Ke A Collins S Ye 2001 PIRA PCR designer for restriction analysis of single nucleotide polymorphisms Bioinformatics 17 838 839 10.1093/ bioinformatics/17.9.838
13. F Li DC Altieri 1999 Transcriptional analysis of human survivin gene expression Biochem J 344 Pt 2 305 311 10.1042/0264-6021:3440305
14. ML McCabe Z Dlamini 2005 The molecular mechanisms of oesophageal cancer Int Immunopharmacol 5 1113 1130 10.1016/j.intimp.2004.11.017
15. A Pickens MB Orringer 2003 Geographical distribution and racial disparity in esophageal cancer Ann Thorac Surg 76 S1367 S1369 10.1016/S0003-4975(03) 01202-5
16. W Salz D Eisenberg J Plescia DS Garlick RM Weiss XR Wu TT Sun DC Altieri 2005 A survivin gene signature predicts aggressive tumor behavior Cancer Res 65 3531 3534 10.1158/0008-5472.CAN-04-4284
17. AI Sarela N Scott J Ramsdale AF Markham PJ Guillou 2001 Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas Ann Surg Oncol 8 305 310 10.1007/s10434-001-0305-0
18. YY Shi L He 2005 SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci Cell Res 15 97 98 10.1038/sj.cr.7290286
19. M Stephens P Scheet 2005 Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation Am J Hum Genet 76 449 462 10.1086/428594
20. M Stephens NJ Smith P Donnelly 2001 A new statistical method for haplotype reconstruction from population data Am J Hum Genet 68 978 989 10.1086/319501
21. VI Ugur SP Kara B Kucukplakci T Demirkasimoglu C Misirlioglu A Ozgen Y Elgin E Sanri K Altundag N Ozdamar 2008 Clinical characteristics and outcome of patients with stage III esophageal carcinoma: a single-center experience from Turkey Med Oncol 25 63 68 10.1007/s12032-007-0043-7
22. M Wagner K Schmelz B Dorken I Tamm 2008 Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia Leuk Res 32 7 1054 1060
23. Y Xu F Fang G Ludewig G Jones D Jones 2004 A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells DNA Cell Biol 23 527 537
24. T Yamamoto N Tanigawa 2001 The role of survivin as a new target of diagnosis and treatment in human cancer Med Electron Microsc 34 207 212 10.1007/s007950100017
25. L Yang DM Parkin L Li Y Chen 2003 Time trends in cancer mortality in China: 1987-1999 Int J Cancer 106 771 783 10.1002/ijc.11300